AtaiBeckley (ATAI) Enterprise Value (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Enterprise Value of -$43.8 million in Q1 2026, up 48.57% quarter-over-quarter from -$85.2 million in Q4 2025, and down 7465.8% on a YoY basis from $594721.3 in Q1 2025.
AtaiBeckley (ATAI) Enterprise Value (2020 - 2026) Analysis & Trends
AtaiBeckley's Enterprise Value history runs 3 years deep, the most recent figure standing at -$43.8 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 7465.8% year-over-year to -$43.8 million; the TTM figure through Mar 2026 stood at -$43.8 million (down 19921.72% YoY), while the FY2025 annual figure was -$85.2 million, down 212.58% from the prior year.
- Enterprise Value was -$43.8 million for Q1 2026 at AtaiBeckley, up from -$85.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$27.2 million in Q4 2024 to a low of -$443.6 million in Q2 2021.
- The 5-year median for Enterprise Value is -$75.7 million (2022), against an average of -$135.8 million.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value tumbled 212.58% in 2025, then tumbled 7465.8% in 2026.
- A 3-year view of Enterprise Value shows it stood at -$27.2 million in 2024, then sank by 212.58% to -$85.2 million in 2025, then jumped by 48.57% to -$43.8 million in 2026.
- The last three Enterprise Value figures came in at -$43.8 million (Q1 2026), -$85.2 million (Q4 2025), and -$579000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -43.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.81 Mn |
| Dec 31, 2025 | -85.17 Mn |
| Sep 30, 2025 | -30.24 Mn |
| Jun 30, 2025 | -61.71 Mn |
| Mar 31, 2025 | -48.87 Mn |
| Mar 31, 2025 | -579,000.00 |
| Dec 31, 2024 | -27.25 Mn |
| Dec 31, 2024 | -27.25 Mn |
| Sep 30, 2024 | -59.37 Mn |
| Jun 30, 2024 | -48.69 Mn |
| Mar 31, 2024 | -38.15 Mn |
| Dec 31, 2023 | -43.68 Mn |
| Sep 30, 2023 | -74.26 Mn |
| Jun 30, 2023 | -138.00 Mn |
| Mar 31, 2023 | -182.07 Mn |
| Dec 31, 2022 | -186.69 Mn |
| Sep 30, 2022 | -135.86 Mn |
| Jun 30, 2022 | -75.69 Mn |
| Mar 31, 2022 | -115.62 Mn |
| Dec 31, 2021 | -353.22 Mn |